AVADEL CNS PHARMACEUTICALS, LLC v. BECERRA

Case No. 22-cv-02159 (APM).

638 F.Supp.3d 23 (2022)

AVADEL CNS PHARMACEUTICALS, LLC, Plaintiff, v. Xavier BECERRA, et al., Defendants. Jazz Pharmaceuticals, Inc., Intervenor-Defendant.

United States District Court, District of Columbia.

Signed November 3, 2022.


Attorney(s) appearing for the Case

Andrew D. Prins , John Richard Manthei , Philip Jonathan Perry , Nicholas L. Schlossman , Latham & Watkins LLP, Washington, DC, for Plaintiff.

Noah T. Katzen , Isaac Belfer , U.S. Department of Justice, Washington, DC, for Defendants.

Kwaku A. Akowuah , Christopher S. Ross , Sean Christopher Griffin , Sidley Austin LLP, Washington, DC, for Intervenor-Defendant.


MEMORANDUM OPINION

I.

Plaintiff Avadel CNS Pharmaceuticals, LLC ("Avadel") is a pharmaceutical company specializing in the development of LUMRYZ,1 a drug for the treatment of narcolepsy. In December 2020, Avadel submitted a...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases